Rheumatology

GLP-1 receptor agonists may reduce cardiovascular risk in autoimmune rheumatic diseases, offering new hope for patients and clinicians.

Trial shows clinical and molecular biomarkers can predict flare risk in rheumatoid arthritis during biologic tapering, supporting personalised treatment strategies.

An MRI-based cohort study shows HLA-B27–positive axial spondyloarthritis is linked to higher inflammation and distinct clinical features, with similar treatment use across groups.

A cross-sectional study finds nearly 80% of women with Sjögren’s syndrome experience sexual dysfunction, underscoring the need for routine assessment and support.

Trial finds diacerein does not improve knee pain in osteoarthritis patients with inflammation, questioning its clinical use.

A UK retrospective analysis finds that baseline lung comorbidities, measured using a rheumatic disease–specific index, are linked to interstitial lung disease risk in rheumatoid arthritis.

A multicentre trial will assess whether a nurse led self management intervention improves skills and quality of life in adults with newly diagnosed inflammatory arthritis.

A phase 2 trial found vunakizumab improved ACR20 response rates in active psoriatic arthritis, with sustained benefits and a favourable safety profile.